These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Warfarin anticoagulation for small-cell lung cancer: evidence against a cytotoxic or anticoagulant mechanism. Silberberg JM; Zucker S J Clin Oncol; 1990 Jan; 8(1):182-4. PubMed ID: 2153191 [No Abstract] [Full Text] [Related]
5. The effect of very-low-dose warfarin on markers of hypercoagulation in metastatic breast cancer: results from a randomized trial. Falanga A; Levine MN; Consonni R; Gritti G; Delaini F; Oldani E; Julian JA; Barbui T Thromb Haemost; 1998 Jan; 79(1):23-7. PubMed ID: 9459316 [TBL] [Abstract][Full Text] [Related]
6. Low-molecular-weight heparin versus placebo for the prevention of venous thromboembolism in metastatic breast cancer or stage III/IV lung cancer. Haas SK; Freund M; Heigener D; Heilmann L; Kemkes-Matthes B; von Tempelhoff GF; Melzer N; Kakkar AK; Clin Appl Thromb Hemost; 2012; 18(2):159-65. PubMed ID: 22275397 [TBL] [Abstract][Full Text] [Related]
7. Dose intensity in cancer chemotherapy. Dodwell DJ; Gurney H; Thatcher N Br J Cancer; 1990 Jun; 61(6):789-94. PubMed ID: 2164831 [No Abstract] [Full Text] [Related]
8. Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer. Levine M; Hirsh J; Gent M; Arnold A; Warr D; Falanga A; Samosh M; Bramwell V; Pritchard KI; Stewart D Lancet; 1994 Apr; 343(8902):886-9. PubMed ID: 7908358 [TBL] [Abstract][Full Text] [Related]
9. Small cell carcinoma of the lung: interaction with the blood coagulation mechanism and treatment with anticoagulants. Zacharski LR Onkologie; 1987 Aug; 10(4):264-70. PubMed ID: 2823201 [TBL] [Abstract][Full Text] [Related]
11. Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate. Final report of VA Cooperative Study #75. Zacharski LR; Henderson WG; Rickles FR; Forman WB; Cornell CJ; Forcier RJ; Edwards RL; Headley E; Kim SH; O'Donnell JF Cancer; 1984 May; 53(10):2046-52. PubMed ID: 6322957 [TBL] [Abstract][Full Text] [Related]
12. A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B. Chahinian AP; Propert KJ; Ware JH; Zimmer B; Perry MC; Hirsh V; Skarin A; Kopel S; Holland JF; Comis RL J Clin Oncol; 1989 Aug; 7(8):993-1002. PubMed ID: 2547030 [TBL] [Abstract][Full Text] [Related]
13. Randomized trial of chemotherapy and radiation therapy with or without warfarin for limited-stage small-cell lung cancer: a Cancer and Leukemia Group B study. Maurer LH; Herndon JE; Hollis DR; Aisner J; Carey RW; Skarin AT; Perry MC; Eaton WL; Zacharski LL; Hammond S; Green MR J Clin Oncol; 1997 Nov; 15(11):3378-87. PubMed ID: 9363869 [TBL] [Abstract][Full Text] [Related]
14. [Results of a cytostatic combination treatment of metastasized breast and small cell bronchial carcinoma during partial blockade of the cell cycle]. Ammon J; Kreidler J; Goronzy J Strahlentherapie Sonderb; 1978; 75():126-33. PubMed ID: 233454 [No Abstract] [Full Text] [Related]
15. Breast lumps: rare presentation of oat cell carcinoma of lung. Kelly C; Henderson D; Corris P J Clin Pathol; 1988 Feb; 41(2):171-2. PubMed ID: 2832451 [TBL] [Abstract][Full Text] [Related]
16. Effect of warfarin on survival in small cell carcinoma of the lung. Veterans Administration Study No. 75. Zacharski LR; Henderson WG; Rickles FR; Forman WB; Cornell CJ; Forcier RJ; Edwards R; Headley E; Kim SH; O'Donnell JR; O'Dell R; Tornyos K; Kwaan HC JAMA; 1981 Feb; 245(8):831-5. PubMed ID: 6257941 [TBL] [Abstract][Full Text] [Related]
17. Intensive combination chemotherapy, concurrent chest irradiation, and warfarin for the treatment of limited-disease small-cell lung cancer: a Cancer and Leukemia Group B pilot study. Aisner J; Goutsou M; Maurer LH; Cooper R; Chahinian P; Carey R; Skarin A; Slawson R; Perry MC; Green MR J Clin Oncol; 1992 Aug; 10(8):1230-6. PubMed ID: 1321892 [TBL] [Abstract][Full Text] [Related]
18. [Carcinoembryonic antigen as an indicator of the effectiveness of the chemotherapy of malignant tumors]. Tkacheva GA; Moroz LV; Polevaia EB; Ozherel'ev AS; Ausekar BV Vestn Akad Med Nauk SSSR; 1986; (5):41-5. PubMed ID: 3014776 [No Abstract] [Full Text] [Related]
19. Fiix-prothrombin time versus standard prothrombin time for monitoring of warfarin anticoagulation: a single centre, double-blind, randomised, non-inferiority trial. Onundarson PT; Francis CW; Indridason OS; Arnar DO; Bjornsson ES; Magnusson MK; Juliusson SJ; Jensdottir HM; Vidarsson B; Gunnarsson PS; Lund SH; Gudmundsdottir BR Lancet Haematol; 2015 Jun; 2(6):e231-40. PubMed ID: 26688233 [TBL] [Abstract][Full Text] [Related]
20. Very low-dose warfarin prophylaxis to prevent thromboembolism in women with metastatic breast cancer receiving chemotherapy: an economic evaluation. Rajan R; Gafni A; Levine M; Hirsh J; Gent M J Clin Oncol; 1995 Jan; 13(1):42-6. PubMed ID: 7799040 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]